Engineering and Development

Management and Executive

Customer Service and Support

Marketing

Accounting and Finance

Arts and Entertainment

Legal and Compliance

Vice President, Global Head of Evidence Generation & Strategic Collaborations

Director, Packaging and Labeling

Kite puts $1.6B on the line to pair up with China’s Pregene for another in vivo CAR-T deal

US government pumps money toward in vivo cell therapy programs

Gilead and Kite Reinforce Bold Commitment to Transform Cancer Care With New Data at ESMO 2025

CAR-T Cell Therapy Isolator Market Outlook 2025-2034 – Insights from Towards Healthcare

Director – Thought Leader Liaison - Multiple Myeloma

Kite Pharma is a biopharmaceutical company focused on developing innovative cancer immunotherapies. The Director – West Thought Leader Liaison for Multiple Myeloma will lead the Opinion Leader Strategy and engage with national and regional myeloma thought leaders to support commercial strategies for Kite in the US market.

Director –Thought Leader Liaison- Multiple Myeloma (US West)

Director, Thought Leader Liaison

Principal Medical Science Liaison

Sign up with Google

Sign in with Google